Animal models of inflammatory bowel disease (IBD) have been useful in the identification of those immune responses uniquely involved in IBD pathogenesis and in defining the important roles of environmental influences, such as normal luminal bacterial flora and the genetic composition of the host, in modifying IBD-associated inflammation. Recent studies have focused particular attention on CD4⁺ T cells which produce excessive quantities either of Th1 cytokines (IFN-γ and TNF) directed by IL-12 or of aTh2 cytokine (IL-4), relative to the production of suppressive cytokines such as IL-10 and transforming growth factor β. Such insights will be extremely beneficial in the development of novel approaches to the control of IBD-type inflammation, such as the use of anticytokine therapies and gene therapy, and, finally, in the identification of the genetic abnormalities and the antigens driving the inflammation that underlies the human disease.